U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226180) titled 'Development and Application of Patient-Derived Models of Cancer' on Sept. 30.
Brief Summary: The purpose of this observational study is to evaluate the clinical utility of investigational patient-derived cancer models, to assess the performance of biomarker-based therapeutic predictions in the patient-derived models.
Each participant in the observational study will have a piece of cancer removed as part of routine, physician direct care and grown in laboratory mice, where multiple anti-cancer drugs can be tested on it simultaneously. Additional data will be provided to the oncologist; interpretation of the results and any clinical ...